Nursing care
Macrolides: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Macrolides such as azithromycin, erythromycin and clarithromycin carry two nursing priorities above all others: QT interval prolongation and extensive interaction with drugs metabolised through the CYP3A4 liver pathway. Check baseline ECG risk factors and the full medication list before giving the first dose, and watch for diarrhoea, hepatotoxicity and hearing changes on longer courses.
Why this drug and not another
Macrolides are reached for when a patient has a penicillin allergy and needs coverage for atypical organisms — Mycoplasma pneumoniae, Legionella, Chlamydia — or common respiratory and skin pathogens. Azithromycin's long half-life makes it attractive for short courses and single-dose regimens for chlamydia; erythromycin remains useful where its prokinetic effect on gastric motility is wanted alongside its antibacterial action.
The trade-off is a drug class that is far from inert pharmacologically. Erythromycin and clarithromycin are strong inhibitors of CYP3A4, azithromycin much less so, which is why azithromycin is often chosen specifically to sidestep interaction risk in patients already on multiple medications. Knowing which macrolide is being given, not just that it is a macrolide, changes what you monitor.
Administration and timing
Erythromycin base is acid-labile and is best given on an empty stomach, one hour before or two hours after food, though enteric-coated and ester formulations tolerate food better — check the specific product. Azithromycin is more forgiving and can usually be given with or without food, though food reduces GI upset. Clarithromycin extended-release tablets should be taken with food.
IV erythromycin is markedly irritating to veins and must be given as a slow, dilute infusion, never as a bolus, with the site monitored for phlebitis. IV azithromycin also requires dilution and a minimum infusion time per the product insert. Space macrolides at least two hours apart from antacids containing aluminium or magnesium, which reduce absorption.
Monitoring parameters
Baseline and follow-up ECG are warranted in patients with existing QT prolongation, bradycardia, uncorrected hypokalaemia or hypomagnesaemia, or those already taking another QT-prolonging drug. Correct potassium and magnesium before starting therapy where possible rather than after a rhythm change appears.
Check liver function in patients on longer courses or with pre-existing hepatic impairment, since macrolides are hepatically metabolised and cholestatic hepatitis is a recognised, if uncommon, effect — erythromycin estolate carries the highest reported risk of the group. Renal function guides dose adjustment for clarithromycin in significant renal impairment. Ask about hearing changes with high-dose or prolonged azithromycin or erythromycin therapy, particularly in older adults.
Adverse effects to report
GI upset — nausea, cramping and diarrhoea — is the most common complaint and is dose-related, worse with erythromycin. Distinguish ordinary diarrhoea from Clostridioides difficile colitis: persistent, watery or bloody diarrhoea beginning during or after the course needs reporting and should not be treated with an antimotility agent alone.
Report palpitations, dizziness or syncope immediately, as these can signal torsades de pointes from QT prolongation. Yellowing of the skin or sclera, dark urine, or right upper quadrant pain point to hepatotoxicity. Tinnitus or hearing loss, though reversible on discontinuation, should also be reported rather than tolerated through the rest of the course.
Contraindications and cautions
Macrolides are contraindicated with a known hypersensitivity to the class and should be avoided or dose-adjusted in significant hepatic impairment, since the liver is both the site of metabolism and a target organ for toxicity. Avoid co-administration with other QT-prolonging agents where an alternative exists, and use caution in patients with myasthenia gravis, as macrolides can worsen neuromuscular weakness.
Clarithromycin and erythromycin are strong CYP3A4 inhibitors and raise serum levels of statins, warfarin, certain benzodiazepines, colchicine and ergot alkaloids, sometimes to dangerous levels — statin-associated rhabdomyolysis and colchicine toxicity are the interactions most often tested. Azithromycin carries a lower but not zero interaction burden and is often the preferred macrolide precisely for this reason in patients on complex regimens.
Teaching points the exam tests
Complete the full course even if symptoms resolve early, and take erythromycin on an empty stomach unless told otherwise for a specific formulation. Patients should report a fast or irregular heartbeat, fainting, or dizziness without delay, and mention every other medication and supplement they take so interactions through liver enzymes can be checked before the drug is started, not after a problem appears.
NCLEX-style items on this class tend to pair a macrolide with another QT-prolonging drug, a statin, or warfarin and ask you to identify the interaction, or they present a patient reporting palpitations after starting azithromycin and ask for the priority nursing action — obtaining an ECG and notifying the prescriber, not reassurance.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Can azithromycin be given with food?
Yes. Azithromycin absorption is not significantly affected by food, and taking it with a meal can reduce the nausea some patients experience. This differs from erythromycin base, which should be taken on an empty stomach.
Why do macrolides interact with so many drugs?
Erythromycin and clarithromycin inhibit the CYP3A4 liver enzyme that metabolises a wide range of medications, including statins, warfarin and certain benzodiazepines, so those drugs accumulate to higher-than-intended levels when given alongside them. Azithromycin has much weaker CYP3A4 inhibition, which is why it is often chosen when a patient is on multiple interacting medications.
What ECG finding would make you hold a macrolide and call the prescriber?
A prolonged QT interval, new bradycardia, or a rhythm change such as torsades de pointes warrants holding the dose and notifying the prescriber immediately. This risk is higher in patients with uncorrected hypokalaemia or hypomagnesaemia, or those already taking another QT-prolonging drug.
Is diarrhoea during macrolide therapy always normal?
Mild GI upset is common and dose-related, but persistent, watery or bloody diarrhoea can indicate Clostridioides difficile colitis and should be reported rather than managed with an antimotility agent. This distinction is a frequent focus of NCLEX items on antibiotic-associated diarrhoea.
More on pharmacology
Guides on this